A survey on trials focussing on the treatment of cannabis-dependence;Studienlage zur behandlung der cannabisabhängigkeit

Fortschritte der Neurologie Psychiatrie

Volumn 74, Issue 4, 2006, Pages 211-225

  Zumdick, S ^a   Schneider, U ^b   Leweke, M ^c   Julicher A ^c   Tossmann, P ^d   Bonnet, Udo ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Beratung und Projektentwicklung mbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

BEHAVIOR; COGNITION; COMORBIDITY; DRUG DEPENDENCE; HEALTH SURVEY; HUMAN; MOTIVATION; PSYCHOSOCIAL DISORDER; REVIEW;

GERMANY; HUMANS; MARIJUANA ABUSE; MULTICENTER STUDIES; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS;

EID: 33646153044     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-870974     Document Type: Review

References (45)

1. Baumann A, Phongsavan P. Epidemiology of substance use in adolescence: prevalence, trends and policy implications. Drug Alcohol Depend 1999; 55: 187-207
2. Kraus L, Augustin R. Repräsentativerhebung zum Gebrauch psychoaktiver Substanzen bei Erwachsenen in Deutschland 2000. München: Institut für Therapieforschung, 2001
3. ElSholy MA, Ross SA, Mehmedic Z, Arafat R, Bao Y, Banahan BF. Potency trends of delta-9-THC and other cannabinoids in confiscated marijuana from 1980 to 1997. J Forensic Sci 2000; 45: 24-30
4. EMCDDA. Is cannabis getting stronger? http://www.emcdda.eu.int, 2004
5. Kraus L, Orth B, Kunz-Ebrecht SR. Alter des Erstkonsums von Cannabis: Altersverschiebung oder mehr Einsteiger? In: Deutsche Hauptstelle gegen die Suchtgefahren (Hrsg.): Jahrbuch Sucht 2004. Neuland: Geesthacht 2003: 124-136
6. Perkonigg A, Lieb R, Höfler M, Schuster P, Sonntag H, Wittchen H-U. Patterns of cannabis use, abuse and dependence over time: incidence, progression and stability in a sample of 1228 adolescents. Addiction 1999; 94: 1663-1678
7. Sydow K von, Lieb R, Pfister H, Höfler M, Sonntag H, Wittchen H-U. The natural course of cannabis use, abuse and dependence over 4 years: a longitudinal community study of adolescents and young adults. Drug Alcohol Depend 2001; 64: 347-361
8. Tossmann HP, Soellner R, Kleiber D. Cannabis - Konsummuster und Gefährdungspotential. In: Deutsche Hauptstelle gegen die Suchtgefahren (Hrsg.) Jahrbuch Sucht 1994. Neuland: Geesthacht, 1993
9. Bonnet U, Harries-Hedder K, Leweke FM, Schneider U, Tossmann P. AWMF-Leitlinie: Cannabis-bezogene Störungen. Fortschr Neurol Psychiatrie 2004; 72: 318-329
10. Fernandez-Ruiz J, Berrendero F, Hernandez ML, Ramos JA. The endogeneous cannabinoid system and brain development. Trends Neurosci 2000; 23: 14-20
11. Mato S, Del Olmo E, Pazos A. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur J Neurosci 2003; 17: 1747-1754
12. Welsch K, Sonntag D. Jahresstatistik 2002 der ambulanten Suchtkrankenhilfe in Deutschland. Sucht 2003; 49, Sonderheft 1: 7-41
13. Welsch K. Jahresstatistik 2001 der stationären Suchtkrankenhilfe in Deutschland. Sucht 2002; 48 Sonderheft 1: S5-S41
14. EBDD - Europäische Beobachtungsstelle für Drogen und Drogensucht. Jahresbericht über den Stand der Drogenproblematik in der Europäischen Union 2003. Luxemburg: Amt für amtliche Veröffentlichungen der Europäischen Gemeinschaften, 2003
15. Simon R, Sonntag D, Bühringer G, Kraus L. Cannabisbezogene Störungen: Umfang, Behandlungsbedarf und Behandlungsangebot in Deutschland. München: IFT, 2004
16. Helou A, Lorenz W, Ollenschläger R, Reinauer H, Schwarz FW. Methodische Standards der Entwicklung evidenz-basierter Leitlinien in Deutschland. T Ärztl Fortbild Qualitätssich 2000; 94: 333-339
17. American Psychiatric Association (APA). Practice guidelines for the treatment of patients with substance abuse disorders: alcohol, cocaine, opioids. Am J Psychiatr 1995; 152: 111-159
18. SIGN Guidelines. An introduction to SIGN methodology for the development of evidenz-based clinical guidelines, SIGN publication 39. Edinburgh: Scottish Intercollegiate Network, 1999 Internet: www.sign.ak.uk
19. Morakinyo O. Aversion Therapy of Cannabis Dependence in Nigeria. Drug Alcohol Depend 1983; 12: 287-293
20. Smith J, Schmeling G, Knowles P. A Marijuana smoking cessation trial utilizing THC-free Marijuana, Aversion Therapy and Self Management Counseling. J Subst Abuse Treatment 1988; 5: 89-98
21. Lang E, Engelander M, Brooke T. Report of an integrated brief intervention with self-defined problem cannabis users. J Subst Abuse Treatment 2000; 19: 111-116
22. Stephens RS, Roffman RA, Simpson EE. Treating adult marijuana dependence: a test of the relapse prevention model. J Consult Clin Psychology 1994; 62: 92-99
23. Budney AJ, Higgins ST, Radonovich KJ, Novy PL. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychology 2000; 68: 1051-1061
24. Miller WR, Rollnick S. Motivational Interviewing: Preparing people to change addictive behavior. New York: Guilford Press, 1991
25. Sinha R, Easton C, Renne-Aubin L, Carroll KM. Engaging young probation-referred Marijuana abusing Individuals in Treatment: A Pilot Trial. The American Journal on Addictions 2004; 12: 314-323
26. Parloff MB. Placebo Controls in Psychotherapy Research: A sine qua non or a placebo for research problems? J Consult Clin Psychology 1986; 54: 79-87
27. Stephens RS, Curtin L, Roffman RA. Comparison of extended versus brief treatments for marijuana use. J Consult Clin Psychology 2000; 68: 898-908
28. Miller WR, Benfield GS, Toningan JS. Enhancing motivation for change in problem drinking: A controlled comparison of two therapist styles. J Consult Clin Psychology 1993; 61: 455-461
29. Copeland J, Swift W, Roffman RA, Stephens RS. A randomised controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. J Subst Abuse Treatment 2001; 21: 55-64
30. Dennis M, Godley SH, Diamond G, Tims FM, Babor T, Donaldson J, Liddle H, Titus JC, Kaminer Y, Webb C, Hamilton N, Funk R. The Cannabis Youth Treatment (CYT) Study: Main findings from two randomized trials. J Subst Abuse Treat 2004; 27: 197-213
31. Dennis M, Godley SH, Diamond GS, Tims FM, Babor T, Donaldson J, Liddle H, Titus JC, Kaminer Y, Webb C, Hamilton N and the CYT- Steering Committee. Main findings of the cannabis youth treatment (CYT) randomized field experiment. 2004; www.chestnut.org/LI/cyt/findings/index.html
32. Stephens RS, Babor TF, Kadden R, Miller M & the Marijuana Treatment Project Group. The Marijuana Treatment Project: rationale, design and participant characteristics. Addiction 2002; 97 (Suppl 1): 109-124
33. The Marijuana Treatment Project Group (MTPG). Brief Treatments for Cannabis Dependence: Findings from a Randomised Multi-Site Trial. J Consult Clin Psychology 2004; 72: 455-466
34. Steinberg KL, Roffmann RA, Carroll KM, Kabela E, Kadden R, Miller M, Duresky D & The Marijuana Treatment Project Group. Tailoring a cannabis dependence treatment for a diverse population. Addiction 2002; 97 (Suppl 1): 109-124
35. Cornelius JR, Salloum IM, Ehler JG, Jarrett PJ, Cornelius MD, Perel JM, Thase ME, Black A. Fluoxetine in depressed alcoholics: A double blind placebo-controlled trial. Arch Gen Psychiatry 1999; 54: 700-705
36. Cornelius JR, Salloum IM, Haskett RF, Ehler JG, Jarrett PJ, Thase ME, Perel JM. Fluoxetine versus placebo for the marijuana use of depressed alcoholics. Addict Behav 1999; 24: 111-114
37. Levin FR, McDowell D, Evans SM, Nunes E, Akerele E, Donovan S, Vosburg SK. Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. The American Journal on Addiction 2004; 13: 21-32
38. Smith NT. A review of the published literature into cannabis withdrawal symptoms in human users. Addiction 2002; 97: 621-632
39. Baker A, Lewin T, Reichler H, Clancy R, Carr V, Garrett R, Sly K, Devir H, Terry M. Evaluation of a motivational interview for substance use within psychiatric in-patient services. Addiction 2002; 97: 1329-1337
40. Cohen J. Statistical power for the behavioral sciences. New York: Academic press, 1988
41. Grawe K, Donati R, Bernauer F. Psychotherapie im Wandel: von der Konfession zur Profession. Göttingen: Hogrefe, 2001
42. Rosenthal RN, Westreich L. Treatment of persons with dual diagnoses of substance use disorders and other psychological problems. In: McCrady BS, Epstein EE (eds). Addictions. A comprehensive guidebook. New York: Oxford University Press, 1999: 439-476
43. Zimmermann P, Mühling S, Sonntag D, Bühringer G, Wittchen H-U. Review on psychotherapeutic interventions for cannabis disorders. Sucht 2004; 50: 334-342
44. Die Drogenbeauftragte der Bundesregierung (Hrsg). Drogen- und Suchtbericht. April 2004
45. Bundesministerium für Gesundheit und Soziale Sicherung. "Jugendkult Cannabis: Risiken und Hilfen". Tagung am 29. und 30.11.2004 in Berlin, Pressestelle, http://www.bmgs.bund.de/deu/gra/aktuelles/ pm/bmgs04/6040_6376.cfm,